BBH

Fund Description
The VanEck Vectors Biotech ETF (BBH) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the Market Vectors US Listed Biotech 25 Index (MVBBHTR). The Index is a rules-based index intended to track the overall performance of 25 of the largest U.S. listed, publicly traded biotech companies.
Fund Profile
Fund Name VanEck Vectors Biotech ETF
Fund Exchange Ticker BBH
Fund Sponsor Van Eck Associates Corporation
Fund ISIN US92189F7261
Net Expense Ratio 0.35 %
Fund Inception Date 20 December 2011
Fund Legal Structure ETF (Open end fund)
Exchange NASDAQ
Listing Country Code US
Fund Investment Objective
ETF Type Specific Global or ExUS Equities - Industry Sector
Asset Class Equities (Stocks)
Index Linked Passive
Index Name Market Vectors US Listed Biotech 25 Index
Index Provider Market Vectors
Currency Hedged No
Inverse / Leveraged Not Applicable
Developed / Emerging Developed Market Funds
Market Capitalization Range Broad Market / Multi-Cap
Growth Value Core / Blend
Continent Not Applicable
Key Statistics
Return As of Date 20 March 2019
Asset Under Management 414.71 Million (USD)
1 Month Total Return 1.05 %
Year To Date Return 17.23 %
1 Year Total Return 9.96 %
3 Year Annualized Total Return 11.66 %
NAV 129.74
Share Outstanding 3,196,500
Top 10 Holdings (20 March 2019)
Constituent Name Constituent Ticker Constituent Type Weighting
AMGEN INC AMGN EQUI 0.0856
GILEAD SCIENCES INC GILD EQUI 0.0634
ALLERGAN PLC AGN EQUI 0.0546
CELGENE CORP CELG EQUI 0.0527
ILLUMINA INC ILMN EQUI 0.0516
IQVIA HOLDINGS INC IQV EQUI 0.0503
BIOGEN INC BIIB EQUI 0.0493
VERTEX PHARMACEUTICALS INC VRTX EQUI 0.0485
REGENERON PHARMACEUTICALS REGN EQUI 0.0468
EXACT SCIENCES CORP EXAS EQUI 0.0465